Concepedia
Statistics
Publications
1
Citations
19
H-Index
Active since
2021
Affiliations
Rubius Therapeutics (United States)(Current)
Maegan Hoover is an author at Rubius Therapeutics (United States).
Publications per year
2021–2021
Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15
Shannon McArdel, Anne‐Sophie Dugast, Maegan Hoover et al. · Cancer Immunology Immunotherapy · 2021 · 19 citations · Full text
1–1 of 1